Showing results (621-630 of 689) with videos related to

Sort By:
Pageof 69
Plos One|September 28, 2011
A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720James S McCarthy, Joanne Marjason, Suzanne Elliott, et al.
Journal of Visualized Experiments : Jove|May 5, 2025
Measuring the Structure, Composition, and Change of Underwater Environments with Large-area ImagingNicole E Pedersen, Vid Petrovic, Hugh Runyan, et al.
Neurology|September 9, 2011
Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trialN Sacktor, S Miyahara, L Deng, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2025
Population pharmacokinetics of penicillin G: insights into increased clearance at low concentrations to guide development of improved long-acting formulations for syphilis and prevention of rheumatic feverOkhee Yoo, Sam Salman, Thel K Hla, et al.
The Journal of Infectious Diseases|April 3, 2020
A Randomized Clinical Trial to Compare Plasmodium falciparum Gametocytemia and Infectivity After Blood-Stage or Mosquito Bite-Induced Controlled Malaria InfectionManon Alkema, Isaie J Reuling, Gerdie M de Jong, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|October 23, 2020
Clinical Nutrition Research and the COVID-19 Pandemic: A Scoping Review of the ASPEN COVID-19 Task Force on Nutrition ResearchJeffrey I Mechanick, Salvatore Carbone, Roland N Dickerson, et al.
The Lancet. Microbe|March 29, 2025
Establishing the lowest penicillin concentration to prevent pharyngitis due to Streptococcus pyogenes using a human challenge model (CHIPS): a randomised, double-blind, placebo-controlled trialThel K Hla, Joshua Osowicki, Julie A Marsh, et al.
Vaccine|May 19, 2019
Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection studyJoshua Osowicki, Kristy I Azzopardi, Ciara Baker, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 studyKimberly A Porter, Stephen R Cole, Joseph J Eron, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2016
Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug DevelopmentJames S McCarthy, Louise Marquart, Silvana Sekuloski, et al.
Pageof 69